Literature DB >> 9210658

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

N J White1.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9210658      PMCID: PMC163932     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  51 in total

1.  Chronotherapy of malaria: an approach to malaria chemotherapy.

Authors:  I Landau; A Chabaud; G Cambie; H Ginsburg
Journal:  Parasitol Today       Date:  1991-12

2.  Studies on Plasmodium berghei Vincke and Lips, 1948. XXIX. The size of parasite population and its relation to the selection of a strain resistant to sulphadiazine.

Authors:  S P RAMAKRISHNAN; S PRAKASH; D S CHOWDHURY; P C BASU
Journal:  Indian J Malariol       Date:  1961-06

3.  Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand.

Authors:  S Looareesuwan; C Viravan; H K Webster; D E Kyle; D B Hutchinson; C J Canfield
Journal:  Am J Trop Med Hyg       Date:  1996-01       Impact factor: 2.345

4.  A contribution to the problem of strains of human plasmodium.

Authors:  P G SHUTE; M MARYON
Journal:  Riv Malariol       Date:  1954-06

5.  Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.

Authors:  F Nosten; S Imvithaya; M Vincenti; G Delmas; G Lebihan; B Hausler; N White
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapy.

Authors:  J R Murphy; D F Clyde; D A Herrington; S Baqar; J R Davis; K Palmer; J Cortese
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

7.  Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand.

Authors:  A L Fontanet; A M Walker
Journal:  Am J Trop Med Hyg       Date:  1993-10       Impact factor: 2.345

8.  Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination.

Authors:  F Nosten; C Luxemburger; F O ter Kuile; C Woodrow; J P Eh; T Chongsuphajaisiddhi; N J White
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

9.  The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.

Authors:  W Peters; B L Robinson
Journal:  Ann Trop Med Parasitol       Date:  1984-10

10.  Antimalarial effects of rifampin in Plasmodium vivax malaria.

Authors:  S Pukrittayakamee; C Viravan; P Charoenlarp; C Yeamput; R J Wilson; N J White
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more
  215 in total

1.  Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics.

Authors:  P J de Vries; N N Bich; H Van Thien; L N Hung; T K Anh; P A Kager; S H Heisterkamp
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  The evolution of tafenoquine--antimalarial for a new millennium?

Authors:  W Peters
Journal:  J R Soc Med       Date:  1999-07       Impact factor: 5.344

3.  Oral artesunate dose-response relationship in acute falciparum malaria.

Authors:  Brian J Angus; Itaporn Thaiaporn; Kenechanh Chanthapadith; Yupin Suputtamongkol; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

4.  Malaria parasites giving rise to recrudescence in vitro.

Authors:  Shusuke Nakazawa; Takashi Maoka; Haruki Uemura; Yoshihiro Ito; Hiroji Kanbara
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 5.  Clindamycin as an antimalarial drug: review of clinical trials.

Authors:  Bertrand Lell; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  The de novo selection of drug-resistant malaria parasites.

Authors:  N J White; W Pongtavornpinyo
Journal:  Proc Biol Sci       Date:  2003-03-07       Impact factor: 5.349

7.  Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand.

Authors:  Srivicha Krudsood; Polrat Wilairatana; Suparp Vannaphan; Sombat Treeprasertsuk; Udomsak Silachamroon; Weerapong Phomrattanaprapin; Victor R Gourdeuk; Gary M Brittenham; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-03       Impact factor: 0.267

8.  Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria.

Authors:  Ric N Price; Anne-Catrin Uhlemann; Michele van Vugt; Al Brockman; Robert Hutagalung; Shalini Nair; Denae Nash; Pratap Singhasivanon; Tim J C Anderson; Sanjeev Krishna; Nicholas J White; François Nosten
Journal:  Clin Infect Dis       Date:  2006-04-26       Impact factor: 9.079

9.  Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.

Authors:  M Imwong; S Pukrittakayamee; S Looareesuwan; G Pasvol; J Poirreiz; N J White; G Snounou
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 10.  Antimalarial drug resistance.

Authors:  Nicholas J White
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.